Trials / Completed
CompletedNCT05644444
Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action
A Two-arm, Parallel-design, Clinical Investigation to Determine the Effectiveness and Safety of a Water-based Personal Lubricant With a Sensory Action and Silicone-based Personal Lubricant With a Sensory Action for the Relief of Intimate Discomfort Associated With Vaginal Dryness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Reckitt Benckiser Healthcare (UK) Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This clinical investigation will look at the effectiveness and safety of two personal lubricants for the relief of intimate discomfort associated with vaginal dryness.
Detailed description
This is an open label, two-arm, parallel-design clinical investigation determining the effectiveness and safety of two personal lubricants. This clinical investigation consists of two phases, a Tolerance Phase and a Treatment Phase, whereby a sub-set of subjects will enter the Tolerance Phase followed by the Treatment Phase. The remaining subjects will enter the Treatment Phase only.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lubricant A (sensate water-based personal lubricant) and Comparator A (non-sensate water-based lubricant) | In the tolerance phase, a pea-sized lubricant will be considered a single application for oral assessment and approximately 3g of lubricant will be considered a single application for vaginal assessment. In the treatment phase, approximately 3g of lubricant will be considered a single application. |
| DEVICE | Lubricant B (sensate silicone-based personal lubricant) and Comparator B (non-sensate silicone-based personal lubricant) | In the tolerance phase, a pea-sized lubricant will be considered a single application for oral assessment and approximately 3g of lubricant will be considered a single application for vaginal assessment. In the treatment phase, approximately 3g of lubricant will be considered a single application. |
Timeline
- Start date
- 2023-02-20
- Primary completion
- 2023-05-05
- Completion
- 2023-05-05
- First posted
- 2022-12-09
- Last updated
- 2025-02-11
- Results posted
- 2025-02-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05644444. Inclusion in this directory is not an endorsement.